REQUEST A DEMO
Total
USD $0.00
Search more companies

SBAL Po Kardiologiya Madara EAD (Bulgaria)

Main Activities: General Medical and Surgical Hospitals
Full name: Spetsializirana Bolnitsa Za Aktivno Lechenie Po Kardiologiya Madara EAD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

SBAL Po Kardiologiya Madara EAD is based in Bulgaria, with the head office in Shumen. It operates in the General Medical and Surgical Hospitals industry. The company was established on 2011. SBAL Po Kardiologiya Madara EAD currently employs 84 (2023) people. From the latest financial highlights, SBAL Po Kardiologiya Madara EAD reported a net sales revenue increase of 25.11% in 2021. A negative growth of 62.06% was recorded in its total assets. In, 2021, the company’s net profit margin increased by 2.73%.

Headquarters
Sofiya 24 vh. 1 et. 1 ap. 3
Shumen; Shumen; Postal Code: 9700

Contact Details: Purchase the SBAL Po Kardiologiya Madara EAD report to view the information.

Basic Information
Total Employees:
Purchase the SBAL Po Kardiologiya Madara EAD report to view the information.
Outstanding Shares:
Purchase the SBAL Po Kardiologiya Madara EAD report to view the information.
Registered Capital:
Purchase the SBAL Po Kardiologiya Madara EAD report to view the information.
Incorporation Date:
2011
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after SBAL Po Kardiologiya Madara EAD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
25.11%
Total operating revenue
33.78%
Operating profit (EBIT)
79%
EBITDA
-10.84%
Net Profit (Loss) for the Period
64.34%
Total assets
-62.06%
Total equity
-0.11%
Operating Profit Margin (ROS)
2.22%
Net Profit Margin
2.73%
Return on Equity (ROE)
-1.97%
Quick Ratio
0.03%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?